AI-assisted, human-published
10/08/2024 /Technology
City Therapeutics Launches with Vision to Lead RNAi-Based Medicine
City Therapeutics, Inc. aims to utilize advanced small interfering RNAs (siRNAs) engineering to establish a strong and sustainable product engine and broaden the therapeutic scope of RNAi-based medicines.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com